[1]AngewandteChemie-InternationalEdition,2008,vol.47,p.4512-4515
[2]JournalofMedicinalChemistry,2010,vol.53,p.3227-3246
[3]TetrahedronLetters,2011,vol.52,p.3266-3270
[4]Patent:WO2019/63748,2019,A1.Locationinpatent:Page/Pagecolumn237
4753-29-1
1198413-08-9 | 9-Bromo-pyrido[1,2-a]pyrimidin-4-one | AA0093IB | MFCD22571306
109932-97-0 | 2-tert-Butyl-n-methylaniline | AA0096WP | MFCD11934511
1380088-03-8 | Kb src 4 | AA009EE7 | MFCD27937762
12036-44-1 | Thulium oxide | AA009RIC | MFCD00011285
1397198-81-0 | 8-Bromo-imidazo[1,2-a]pyridine-3-carboxylic acid ethyl ester | AA009W57 | MFCD27991964
1276615-05-4 | 3,5-Dibromo-pyridine-2,6-diamine hydrobromide | AA00A0PL | MFCD30478178
1445085-97-1 | Xantphos Pd G3 | AA00ADY3 | MFCD22572675
15453-87-9 | INDIUM TRIFLUOROACETYLACETONATE | AA00AQ59 | MFCD00058830
147494-20-0 | Methyl 2-amino-6-iodobenzoate | AA00AUQY | MFCD16036889
27057-09-6 | Bis(triphenylphosphino)(2-methylphenyl)chloronickel(II) | AA00BJDE | MFCD28144558